debate: best second-line approach to induce lymphoma remission prior to sct? - chemotherapy
Published 8 years ago • 122 plays • Length 12:04Download video MP4
Download video MP3
Similar videos
-
15:15
debate: best second-line approach to induce lymphoma remission prior to sct? - brentuximab
-
15:04
debate: best second line therapy for relapsed hodgkin lymphoma - brentuximab alone/ chemo
-
14:34
debate: best pre-transplant second line therapy for relapsed hodgkin lymphoma - chemo alone
-
13:16
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - sct-based therapy
-
15:00
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - radiation therapy
-
9:33
bone marrow transplant advice | tips for the patient | leukaemia | lymphoma | cancer
-
7:45
active monitoring for follicular lymphoma: louize's story
-
6:23
stem cell transplantation as a treatment option for lymphoma | everything you need to know
-
22:46
follicular lymphoma debate: does chemotherapy have a major role to play?
-
16:32
debate: best upfront approach for advanced stage hodgkin lymphoma? - a (brentuximab vedotin) vd
-
2:03:01
current and future management of non-small cell lung cancer with an egfr mutation
-
22:46
follicular lymphoma debate: chemotherapy no longer has a major role in the treatment
-
27:49
hodgkin disease: the past, the present, and the future
-
15:25
debate: young patient with recurrent follicular lymphoma and short remission? - transplant therapies
-
13:03
debate: hodgkin lymphoma patient who relapses after autologous sct - allogeneic sct
-
12:45
debate: should maintenance rituximab be used in follicular lymphoma? - no
-
16:20
debate: follicular lymphoma patient with early progression - autologous stem cell transplant
-
14:29
debate: what is the best approach for relapsed t cell lymphoma? - allosct
-
8:40
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - no
-
10:46
debate: value to using brentuximab vedotin consolidation early after auto-sct in hodgkin's? - yes
-
11:54
debate: recurrent hodgkin's lymphoma after asct in cr on brentuximab vedotin - maintenance
-
14:44
debate: follicular lymphoma patient with early progression - novel agents